Initially, it was thought that the neutrophil dichotomy primarily stems from the presence or absence of tumor microenvironmental factors that promote either protumorigenic (TGF-b) [54] or antitumorigenic (type I IFN) [56] neutrophil activity. This evidence concerns the gene TGFB1 and neoplasm.